[Technology using the special antibody CSV developed by the University of Texas MD Anderson Cancer Center, the No. 1 ranked cancer research and treatment facility in the United States] Approximately 2 in 3 men and 1 in 2 women will develop cancer in their lifetime. Early detection through regular screening is crucial for cancer, and the Micro CTC test captures the cancer cells themselves that have leaked into the blood. With a single 5-minute blood draw, it can screen for cancer risk (excluding blood cancers) and diagnose cancer risk throughout the body. Unlike other cancer tests, the Micro CTC test carries absolutely no risk of radiation exposure. It is gaining attention because the test can be done even during a busy schedule.